629
Views
20
CrossRef citations to date
0
Altmetric
Commentary

The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability

&
Pages 153-158 | Published online: 18 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Michael E Schatman & Matthew G Fortino. (2020) The Problem (and the Answer?) to the Limited Availability of Pain Psychologists: Can Clinical Social Workers Help?. Journal of Pain Research 13, pages 3525-3529.
Read now
Michael E Schatman, Hannah Shapiro & Jeffrey Fudin. (2020) The Repeal of the Affordable Care Act and Its Likely Impact on Chronic Pain Patients: “Have You No Shame?”. Journal of Pain Research 13, pages 2757-2761.
Read now
Kathryn Duensing, Robert Twillman, Stephen Ziegler, M Soledad Cepeda, David Kern, Maribel Salas & Gregory Wedin. (2020) An Examination of State and Federal Opioid Analgesic and Continuing Education Policies: 2016–2018. Journal of Pain Research 13, pages 2431-2442.
Read now
Michael E Schatman, Alexis Vasciannie & Ronald J Kulich. (2019) Opioid moderatism and the imperative of rapprochement in pain medicine. Journal of Pain Research 12, pages 649-657.
Read now
Lisa Lynn Dragic, Jeffrey Fudin & Michael E Schatman. (2018) Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids. Journal of Pain Research 11, pages 2295-2299.
Read now
Lynn R. Webster, John Markman, Edward J. Cone & Gwendolyn Niebler. (2017) Current and future development of extended-release, abuse-deterrent opioid formulations in the United States. Postgraduate Medicine 129:1, pages 102-110.
Read now
Michael E Schatman. (2016) A glimmer of hope in American pain medicine?. Journal of Pain Research 9, pages 509-513.
Read now

Articles from other publishers (12)

Katie Fitzgerald Jones, Lindsay Bell Abdulhay, Steve R. Orris, Jessica S. Merlin, Yael Schenker & Hailey W. Bulls. (2022) The Relevance of State Laws Regulating Opioid Prescribing for People Living With Serious Illness. Journal of Pain and Symptom Management 64:2, pages 89-99.
Crossref
Svetlana Beilfuss & Sebastian Linde. (2021) Pharmaceutical opioid marketing and physician prescribing behavior. Health Economics 30:12, pages 3159-3185.
Crossref
Mohammad S. Jalali, Emily Ewing, Calvin B. Bannister, Lukas Glos, Sara Eggers, Tse Yang Lim, Erin Stringfellow, Celia A. Stafford, Rosalie Liccardo Pacula, Hawre Jalal & Reza Kazemi-Tabriz. (2021) Data Needs in Opioid Systems Modeling: Challenges and Future Directions. American Journal of Preventive Medicine 60:2, pages e95-e105.
Crossref
Xuelei Hu, Marcus Gallagher, William Loveday, Abhilash Dev & Jason P. Connor. (2020) Network Analysis and Visualisation of Opioid Prescribing Data. IEEE Journal of Biomedical and Health Informatics 24:5, pages 1447-1455.
Crossref
Nicoleta Stoicea, Andrew Costa, Luis Periel, Alberto Uribe, Tristan Weaver & Sergio D. Bergese. (2019) Current perspectives on the opioid crisis in the US healthcare system. Medicine 98:20, pages e15425.
Crossref
Jeffrey Fudin, Amelia L Persico, Jeffrey J Bettinger & Erica L Wegrzyn. (2019) The state of naloxone: Access amid a public health crisis. Medicine Access @ Point of Care 3, pages 239920261984763.
Crossref
Gary M. Reisfield & Roger L. Bertholf. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing 343 358 .
Joshua P. Cohen, Mario Mendoza & Carl Roland. (2018) Challenges Involved in the Development and Delivery of Abuse-deterrent Formulations of Opioid Analgesics. Clinical Therapeutics 40:2, pages 334-344.
Crossref
Christian Compagnone, Michael E. SchatmanRichard L. RauckJan Van Zundert, Monika Kraus, Dragan Primorac, Frances WilliamsMassimo Allegri, Gloria Saccani Jordi & Guido Fanelli. (2017) Past, Present, and Future of Informed Consent in Pain and Genomics Research: Challenges Facing Global Medical Community. Pain Practice 17:1, pages 8-15.
Crossref
Emily A. Karanges, Bianca Blanch, Nicholas A. Buckley & Sallie-Anne Pearson. (2016) Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. British Journal of Clinical Pharmacology 82:1, pages 255-267.
Crossref
Michael E. Schatman & Janet L. Thoman. (2015) Valid Psychological Injury Claims: Respecting the Needs of Survivors. Psychological Injury and Law 8:4, pages 311-322.
Crossref
Svetlana Beilfuss. (2019) Pharmaceutical Opioid Marketing and Physician Prescribing Behavior. SSRN Electronic Journal.
Crossref